The digital project MigraAgile, promoted by the Hospital Clínic Barcelona in collaboration with the Primary Care Centres of the Barcelona Esquerra In1
The number of visits to the Hospital Clínic Barcelona Headache and Facial Pain Unit increased by 38% over the last year (1,338 new cases in one year)1
A programme at Clínic Barcelona demonstrates the effectiveness of therapeutic patient education in reducing headache days and improving quality of li1
Researchers at the Clínic-IDIBAPS coordinated a study that highlights the efficacy of migraine treatment with a monoclonal antibody, galcanezumab, in1
Vydura, a medication for the acute, preventive treatment of episodic migraine, has been approved. Its active ingredient is rigemepant and is indicate1
